Effectiveness of Sulfasalazine Therapy Following Mesalazine Treatment Failure in Children with Ulcerative Colitis
Paola Ruška, Ines Doder, Ana Močić Pavić, Zrinjka Mišak, Sanja Kolaček, Iva Hojsak · 2026
Read Effectiveness of Sulfasalazine Therapy Following Mesalazine Treatment Failure in Children with Ulcerative Colitis by Paola Ruška, Ines Doder, Ana Močić Pavić, Zrinjka Mišak, Sanja Kolaček, Iva Hojsak (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13591158.txt.
Description
Paola Ruška and five colleagues published a children's bowel study in two thousand twenty-six on drug choices for ulcerative colitis. When the standard drug mesalazine fails, doctors must pick the next step. One older option, sulfasalazine, is cheap but less often used in children.
The team reviewed records of children diagnosed over a decade who relapsed on mesalazine alone. Ninety-nine children qualified; about a third switched to sulfasalazine. The switch worked for four in five of them, and over half stayed relapse-free for a year. Time without relapse did not differ clearly among the three drug paths compared. Children switched to sulfasalazine had wider disease than those staying on mesalazine. The authors call the switch a fair option for mild to moderate cases.
Catalog record
| CREATOR | Paola Ruška, Ines Doder, Ana Močić Pavić, Zrinjka Mišak, Sanja Kolaček, Iva Hojsak |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |